A few years ago I met a Persian named Biscuit in the exam room — a cloud of orange fluff with perpetually weeping eyes and an owner who was deeply frustrated. She had tried medicated eye wipes, a prescription antibiotic course, and three different hypoallergenic diets. The discharge would clear up, stay gone for a couple of months, then come back just as thick and rust-stained as before. When I mentioned feline herpesvirus and suggested trying L-lysine as a daily supplement, she looked at me the way most people do when a vet starts talking amino acids: skeptical, slightly lost, and wondering why something from the supplement aisle might matter.
It’s a fair response. L-lysine has accumulated a peculiar reputation — enthusiastically recommended by some vets, dismissed by others, and described on most product pages with claims that rarely survive close reading. What follows is an honest account of what L-lysine actually does in a cat’s body, what the research says about its specific use against feline herpesvirus, and where its role in tear stain formulas fits into the broader picture.
What L-lysine is
L-lysine is an essential amino acid. “Essential” has a specific meaning here: mammals cannot synthesize it from other compounds, which means cats — and humans — must obtain it entirely from diet or supplementation. It’s one of the nine essential amino acids, and it’s present in meaningful concentrations in muscle meat, fish, and eggs.
Inside the body, lysine does several things at once. It’s a building block for structural proteins. It participates in collagen cross-linking, the process that gives connective tissue its tensile strength. It’s also the obligate precursor for carnitine synthesis, which is critical for fatty acid transport into mitochondria. And in feline nutrition specifically, where taurine deficiency was already recognized as a serious concern, the broader picture of amino acid adequacy matters.
Most cats eating a complete commercial diet aren’t lysine-deficient. But supplementation still has a rationale — and it isn’t about making up a dietary shortfall. It’s about exploiting something specific in the way certain viruses replicate.
The feline herpesvirus connection
Feline herpesvirus type 1 (FHV-1) is extraordinarily common. Estimates place the prevalence of latent infection somewhere between 70% and 97% of the domestic cat population — which means if you have a cat that was ever in a shelter, a cattery, or contact with other cats as a kitten, there’s a reasonable chance FHV-1 is already present in their trigeminal ganglia, dormant and waiting (Thiry et al., 2009). That’s not a crisis. Most latently infected cats never show clinical signs. But stress, illness, or immunosuppression can trigger reactivation — and when it does, the classic signs are upper respiratory: sneezing, nasal discharge, conjunctivitis, and the eye discharge that produces tear staining.
Here’s where lysine becomes relevant. FHV-1, like other herpesviruses, has an unusually high requirement for arginine to replicate. Arginine is another amino acid — and lysine competes with it for the same intestinal absorption transporters. When dietary lysine is elevated, arginine absorption is suppressed. In theory, this creates a less favorable biochemical environment for viral replication during an active outbreak.
The mechanism is real. The question is whether supplementing a cat’s diet actually shifts that balance enough to matter clinically.
What the evidence actually shows
The honest answer is: the research is genuinely mixed, and anyone who tells you otherwise in either direction is glossing over the nuance.
Early studies were encouraging. Maggs (2005) reviewed the pathogenesis and management of FHV-1 and noted L-lysine as a reasonable adjunct with a plausible mechanism. Stiles et al. (2002) conducted a controlled study in which cats with experimentally induced FHV-1 conjunctivitis received oral L-lysine or placebo, and reported that the lysine group had less severe clinical signs. That finding got lysine onto a lot of veterinary recommendation lists, and it’s been there ever since.
The problem is that later work has been less supportive. Rees & Lubinski (2008) found that lysine supplementation didn’t prevent rhinotracheitis virus infections or reduce recurrence rates in a shelter population. More significantly, Bol & Bunnik (2015) published a systematic review in BMC Veterinary Research that examined all available controlled trials and concluded there was insufficient evidence to recommend L-lysine for the prevention or treatment of FHV-1 infection. Their critique included concerns about study design, dosing variability, and the failure of most trials to account for confounding variables in multi-cat environments.
That’s a serious critique from a well-structured review. It doesn’t prove lysine is useless — it proves the evidence base isn’t strong enough to issue a confident recommendation either way. The honest position, as of today, is that the debate continues. A number of veterinary dermatologists and ophthalmologists still use it in clinical practice; others have quietly moved away from it.
Why it’s still widely used
Several things keep L-lysine in active use despite the inconclusive evidence.
First, the safety profile is genuinely favorable. At doses used in cats, it doesn’t accumulate to toxic levels and hasn’t been associated with clinically significant adverse effects. When the mechanism is plausible and the downside is low, many clinicians apply a pragmatic cost-benefit framework.
Second, anecdotal veterinary experience carries weight even where controlled trials fall short. Practitioners who work with breeding colonies, multi-cat households, and cats with documented FHV-1 recurrence often report that consistent lysine supplementation correlates with less frequent flare-ups. Anecdote isn’t data, but it isn’t nothing.
Third — and this is underappreciated — most real-world supplement products combine L-lysine with other ingredients. In multi-ingredient formulas, attributing benefit to a single component is difficult. This cuts both ways: it means we can’t prove lysine is doing the work, but it also means the skeptical studies may not fully capture what happens when lysine is part of a broader supportive regimen.
L-lysine and tear staining
Tear staining in cats with FHV-1 history isn’t a coincidence. The virus creates ocular pathology directly — conjunctivitis, corneal ulceration in severe cases, and especially excessive lacrimation. More tearing means more porphyrin-containing fluid tracking down the muzzle, more substrate for microbial growth, and the characteristic rusty-brown staining on facial fur.
If L-lysine supplementation helps reduce the frequency or severity of FHV-1 reactivation episodes — even modestly — the downstream effect is less ocular discharge, and therefore less tear staining. It’s an indirect pathway, but a logical one. This is why lysine appears in tear stain formulas alongside other ingredients targeting the ocular environment. The goal isn’t to bleach the fur; it’s to reduce the source of the staining.
For cats with a confirmed FHV-1 history and recurrent tearing, this ingredient combination is worth considering as part of a multi-pathway approach. For cats whose tear staining has a different root cause — nasal anatomy, dietary iron, or microbiome issues — the lysine component will be less relevant, and the other ingredients in the formula take on more importance.
L-lysine and mucin production
One mechanism sometimes cited in product descriptions is that lysine supports mucin synthesis in the ocular surface or GI mucosa. This is partly accurate and partly conflated. L-threonine is the direct amino acid precursor for mucin glycoproteins; that’s well established. Lysine isn’t.
What lysine does contribute is collagen and glycoprotein synthesis more broadly. Healthy mucosal architecture in the conjunctiva depends on connective tissue scaffolding, and lysine is part of that supply chain. But it’s worth being precise: lysine supports general tissue integrity, not mucin synthesis specifically.
How to supplement
Standard veterinary guidance for cats falls in the range of 250–500 mg per day. Lower doses (around 250 mg) are used for maintenance in otherwise healthy cats with a history of herpesvirus episodes; higher doses are sometimes suggested during active outbreaks, though the evidence supporting high-dose supplementation is particularly thin.
Powder formulas are generally more practical than treats for cats. Powder mixes evenly into wet food and avoids the palatability lottery of getting a cat to reliably eat a treat-based product. Consistency matters more than dosing timing — studies on lysine typically required daily administration for weeks to months before any benefit was apparent. Short courses aren’t likely to shift arginine metabolism in a meaningful way.
The Petterm Tear Stain Powder includes 100 mg of L-lysine per serving alongside lactoferrin and lutein. At that concentration it’s positioned as a maintenance ingredient within a broader formula rather than a standalone lysine supplement — which reflects the multi-pathway approach that most modern tear stain products take.
For cats under veterinary management for active FHV-1 disease, lysine is typically one part of a protocol that may also include antiviral medications like famciclovir and supportive eye care. Supplementation doesn’t replace that conversation.
What L-lysine won’t do
It’s equally important to be clear about the limits. L-lysine isn’t a broad-spectrum antiviral. It doesn’t eliminate FHV-1 from the trigeminal ganglia; once a cat is infected, the virus is latent for life. Lysine supplementation, even in the most optimistic reading of the evidence, may help moderate outbreak frequency and severity — it doesn’t clear the infection.
It also won’t resolve bacterial conjunctivitis. Purulent discharge, rapid-onset eye swelling, or unilateral eye problems warrant a veterinary evaluation and are likely to need antimicrobial treatment, not amino acid supplementation. Lysine’s putative mechanism is specific to arginine-dependent viruses; it doesn’t affect bacterial growth in the conjunctiva at all.
And for cats whose tear staining has nothing to do with FHV-1 — breeds with nasal conformation issues, cats with chronic dietary iron excess, or cats with sebaceous overproduction — lysine won’t move the needle on staining. Understanding the underlying cause of tearing matters before reaching for any supplement.
If you’re managing a cat with recurrent eye discharge, see also our article on multi-pathway feline health support through probiotics, and for a cross-species overview of tear staining mechanisms, the guide on tear stain causes and solutions covers the biochemical fundamentals that apply to both dogs and cats.
Frequently asked questions
Is L-lysine safe for cats? At doses typically used in supplements (250–500 mg/day), L-lysine is well-tolerated in cats. No clinically significant adverse effects have been consistently reported. That said, it’s worth telling your vet you’re using it, particularly if your cat is on other medications or has kidney disease — kidney function affects amino acid handling generally.
How long before I see a difference? The existing studies used supplementation periods of four to twelve weeks before assessing outcomes. Don’t expect rapid change. If you’re trialing L-lysine for herpesvirus-related symptoms, give it at least two to three months of consistent daily use before deciding whether it’s contributing.
Can L-lysine replace antiviral medications for FHV-1? No. For cats with active, severe herpesvirus episodes, famciclovir and veterinary-prescribed antivirals are the standard of care. Lysine may be used alongside those treatments as a supportive measure, not as a replacement.
Does it matter what form the lysine is in — powder vs. treats? The amino acid is the same regardless of delivery format. Practically, powder mixes into wet food more reliably and avoids palatability issues that can make treat compliance inconsistent. Choose whatever your cat will actually eat every day.
My cat doesn’t have herpesvirus. Should I still use lysine? If tear staining is coming from a non-herpetic cause, lysine is less likely to be a significant factor. Other ingredients in a tear stain formula — lactoferrin for iron sequestration, lutein for ocular surface support — would be more directly relevant to non-viral tear staining.
Is lysine supplementation in cats the same as in humans? The amino acid is identical, but the rationale differs. In humans, lysine supplementation is used for its role in collagen and for arginine competition against human herpes simplex virus. In cats, the target is FHV-1. The mechanism is analogous but the species-specific viral biology differs.
References
- Maggs, D.J. (2005). Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clinical Techniques in Small Animal Practice, 20(2), 94–101.
- Bol, S. & Bunnik, E.M. (2015). Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: a systematic review. BMC Veterinary Research, 11, 284.
- Stiles, J., et al. (2002). Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats. Am J Vet Res, 63(1), 99–103.
- Rees, T.M. & Lubinski, J.L. (2008). Oral supplementation with L-lysine did not prevent rhinotracheitis virus infections or recurrences. J Feline Med Surg, 10(6), 510–513.
- Thiry, E., et al. (2009). Feline herpesvirus infection: ABCD guidelines on prevention and management. J Feline Med Surg, 11(7), 547–555.
This article is for educational purposes and is not veterinary medical advice. Petterm products are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Always consult your veterinarian before introducing a new supplement, especially if your cat has an existing eye condition, takes medication, or is under 8 weeks old.